API | dextroamphetamine

dextroamphetamine (Dexedrine) Report issue

Small molecule Approved ^FDA

AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW

DEXTROAMPHETAMINE TANNATE is a salt of dextroamphetamine, amphetamine enantiomer. It is used as CNS stimulant in the treatment of attention deficit hyperactivity disorder. ^NCATS

Chemistry

SMILES: C[C@H](N)Cc1ccccc1.O[C@@H]([C@H](O)[C@H](O)C(=O)O)[C@@H](O)C(=O)O
InChIKey: VHKVKWTWHZUFIA-DGOKBZBKSA-N
Mol. Mass: 345.35
ALogP: 1.58 Partition coefficient
ChEMBL Molecules:

dextroamphetamine saccharate

dextroamphetamine adipate

None

dextroamphetamine sulfate

dextroamphetamine

More Chemistry

Pharmacology

Mechanisms of Action:
- Sodium-dependent dopamine transporter (Homo sapiens) ^UniProt
- Sodium-dependent noradrenaline transporter (Homo sapiens) ^UniProt
- Synaptic vesicular amine transporter (Homo sapiens) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Prescription Only
Delivery Methods: Oral
Pro Drug: No

Drug Pricing (per unit)

United States

$0.0462 - $17.5416

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Combination drugs

biphetamine ( amphetamine (Adderall), dextroamphetamine (Dexedrine) - other names: adderall, adderall xr, dextroamp saccharate, amp aspartate, dextroamp sulfate and amp sulfate, dextroamp saccharate,amp aspartate,dextroamp sulfate and amp sulfate, mydayis )

Organizations (79)

Research & Development (20)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (59)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (16)

Approved Indications (3)

Aortic Valve Insufficiency

Attention Deficit Disorder with Hyperactivity

Narcolepsy

Experimental Indications - Clinical Trial Phases 1-4 (15)

Affect (Phase 2)

Attention Deficit and Disruptive Behavior Disorders (Phase 2)

Attention Deficit Disorder with Hyperactivity ()

Bipolar Disorder (Phase 1)

Central Nervous System Stimulants (Phase 4)

Cocaine-Related Disorders (Phase 2)

Cognitive Dysfunction (Phase 4)

COVID-19 (Phase 4)

Deception (Phase 4)

Fetal Alcohol Spectrum Disorders (Phase 4)

Healthy Volunteers (Phase 3)

Idiopathic Hypersomnia (Phase 2)

Memory, Short-Term (Phase 2)

Motivation (Phase 4)

Narcolepsy (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 13
# of Trial Organizations: 20

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue